aTyr Pharma Announces First Quarter 2017 Operating Results
May 11, 2017 16:05 ET
|
aTyr Pharma Inc.
– Announced Promising Top-Line Results from ResolarisTM Phase 1b/2 Trial in Early Onset FSHD –– Preclinical Data from StalarisTM Program to be Presented at American Thoracic Society...